Melissa Amundson, DDS
Oral & Maxillofacial Surgery · Tallahassee, FLNPI 1689823619
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,905 of the $3,466 with a category attached, or 83.8%. 14 manufacturers reported payments, led by Kls-martin L.p. at 46.8% of the total. Reporting peaked in 2022 at $939 and has fallen 52.1% since, to $450 in 2025.
Across 48 payments — averaging $72.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kls-martin L.p.$2K
- Stryker$812
- Johnson & Johnson$415
- Kerecis Limited$294
- AstraZeneca$73
- Smith+Nephew$53
- plus $198 from 8 others
What the payments were for
- Travel & lodging$56016%
- Food & beverage$2,90584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kls-martin L.p. | 16 | $1,621 |
| Stryker | 7 | $812 |
| Johnson & Johnson(2 entities) | 6 | $415 |
| Kerecis Limited | 3 | $294 |
| AstraZeneca | 4 | $73 |
| Smith+Nephew | 3 | $53 |
| Henry Schein, Inc. | 1 | $40 |
| Teleflex LLC | 1 | $38 |
| Colgate Oral Pharmaceuticals, Inc. | 2 | $28 |
| Eagle Pharmaceuticals, Inc. | 1 | $21 |
| Solventum Corporation | 1 | $20 |
| Octapharma USA, Inc. | 1 | $20 |
| Davol Inc. | 1 | $19 |
| Zimmer Biomet | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,466 in reported general payments places this provider in the 80th percentile of 498 oral & maxillofacial surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 68 | $220 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $206 |
| Ibuprofen | 25 | $146 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $100 |
| Amoxicillin | 32 | $85 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Tallahassee
- Michael PikosPalm Harbor$3M
- Ramon RuizOrlando$846K
- Curtis SchalitDaytona Beach$333K
- Rui FernandesJacksonville$107K
- Tyler HolleyOrlando$55K
- Shaun YoungNew Port Richey$46K
- Eduardo NicolaievskyMiami Beach$45K
- Craig MischSarasota$43K
- Jose MonteroMiami$42K
- Ramzey TursunMiami$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.